Skip to Main Content

Author Details

Carole L Yauk
University of Ottawa
1996
226
45
PMIDPaper TitleJournal TitlePublished Year
36534918In vitro transcriptomic analyses reveal pathway perturbations, estrogenic activities, and potencies of data-poor BPA alternative chemicals.Toxicol Sci2023
37941476Toxicological Mechanisms and Potencies of Organophosphate Esters in KGN Human Ovarian Granulosa Cells as Revealed by High-throughput Transcriptomics.Toxicol Sci2023
37889188Report of the 3rd and 4th Mystery of Reactive Oxygen Species Conference.ALTEX2023
38058303The functional mutational landscape of the <i>lacZ</i> gene.iScience2023
37341741Duplex sequencing provides detailed characterization of mutation frequencies and spectra in the bone marrow of MutaMouse males exposed to procarbazine hydrochloride.Arch Toxicol2023
36646809Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing.Nat Rev Drug Discov2023
36881459Considerations for application of benchmark dose modeling in radiation research: workshop highlights.Int J Radiat Biol2023
36754249DNA methylation changes from primary cultures through senescence-bypass in Syrian hamster fetal cells initially exposed to benzo[a]pyrene.Toxicology2023
36534918In vitro transcriptomic analyses reveal pathway perturbations, estrogenic activities, and potencies of data-poor BPA alternative chemicals.Toxicol Sci2023
37491114Error-corrected duplex sequencing enables direct detection and quantification of mutations in human TK6 cells with strong inter-laboratory consistency.Mutat Res Genet Toxicol Environ Mutagen2023
37491114Error-corrected duplex sequencing enables direct detection and quantification of mutations in human TK6 cells with strong inter-laboratory consistency.Mutat Res Genet Toxicol Environ Mutagen2023
38058303The functional mutational landscape of the <i>lacZ</i> gene.iScience2023
37889188Report of the 3rd and 4th Mystery of Reactive Oxygen Species Conference.ALTEX2023
37941476Toxicological Mechanisms and Potencies of Organophosphate Esters in KGN Human Ovarian Granulosa Cells as Revealed by High-throughput Transcriptomics.Toxicol Sci2023
37341741Duplex sequencing provides detailed characterization of mutation frequencies and spectra in the bone marrow of MutaMouse males exposed to procarbazine hydrochloride.Arch Toxicol2023
36754249DNA methylation changes from primary cultures through senescence-bypass in Syrian hamster fetal cells initially exposed to benzo[a]pyrene.Toxicology2023
36881459Considerations for application of benchmark dose modeling in radiation research: workshop highlights.Int J Radiat Biol2023
36646809Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing.Nat Rev Drug Discov2023
35247516R-ODAF: Omics data analysis framework for regulatory application.Regul Toxicol Pharmacol2022
35902794Duplex sequencing identifies genomic features that determine susceptibility to benzo(a)pyrene-induced in vivo mutations.BMC Genomics2022
35445829Comprehensive interpretation of in vitro micronucleus test results for 292 chemicals: from hazard identification to risk assessment application.Arch Toxicol2022
36165699A Transformative Vision for an Omics-Based Regulatory Chemical Testing Paradigm.Toxicol Sci2022
35573988Brief Developmental Exposure to Fluoxetine Causes Life-Long Alteration of the Brain Transcriptome in Zebrafish.Front Endocrinol (Lausanne)2022
35573276A Case Study on Integrating a New Key Event Into an Existing Adverse Outcome Pathway on Oxidative DNA Damage: Challenges and Approaches in a Data-Rich Area.Front Toxicol2022
35435297Introducing AOP Reports: Collaborative review and publication of adverse outcome pathways.Environ Mol Mutagen2022
36211197Integrated Genotoxicity Testing of three anti-infective drugs using the TGx-DDI transcriptomic biomarker and high-throughput CometChip<sup>®</sup> assay in TK6 cells.Front Toxicol2022
35939396Evaluating the influences of confounding variables on benchmark dose using a case study in the field of ionizing radiation.Int J Radiat Biol2022
35939275Benchmark dose modeling of transcriptional data: a systematic approach to identify best practices for study designs used in radiation research.Int J Radiat Biol2022
35939057Deploying elements of scoping review methods for adverse outcome pathway development: a space travel case example.Int J Radiat Biol2022
35875696Reactive Oxygen Species in the Adverse Outcome Pathway Framework: Toward Creation of Harmonized Consensus Key Events.Front Toxicol2022
36271823Impact of sampling time on the detection of mutations in rapidly proliferating tissues using transgenic rodent gene mutation models: A review.Environ Mol Mutagen2022
35404422A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies.Toxicol Sci2022
35777453A gene expression biomarker identifies inhibitors of two classes of epigenome effectors in a human microarray compendium.Chem Biol Interact2022
35315142AOP report: Development of an adverse outcome pathway for oxidative DNA damage leading to mutations and chromosomal aberrations.Environ Mol Mutagen2022
35247516R-ODAF: Omics data analysis framework for regulatory application.Regul Toxicol Pharmacol2022
35404422A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies.Toxicol Sci2022
35435297Introducing AOP Reports: Collaborative review and publication of adverse outcome pathways.Environ Mol Mutagen2022
35573988Brief Developmental Exposure to Fluoxetine Causes Life-Long Alteration of the Brain Transcriptome in Zebrafish.Front Endocrinol (Lausanne)2022
35573276A Case Study on Integrating a New Key Event Into an Existing Adverse Outcome Pathway on Oxidative DNA Damage: Challenges and Approaches in a Data-Rich Area.Front Toxicol2022
35777453A gene expression biomarker identifies inhibitors of two classes of epigenome effectors in a human microarray compendium.Chem Biol Interact2022
35445829Comprehensive interpretation of in vitro micronucleus test results for 292 chemicals: from hazard identification to risk assessment application.Arch Toxicol2022
35875696Reactive Oxygen Species in the Adverse Outcome Pathway Framework: Toward Creation of Harmonized Consensus Key Events.Front Toxicol2022
36211197Integrated Genotoxicity Testing of three anti-infective drugs using the TGx-DDI transcriptomic biomarker and high-throughput CometChip<sup>®</sup> assay in TK6 cells.Front Toxicol2022
35939396Evaluating the influences of confounding variables on benchmark dose using a case study in the field of ionizing radiation.Int J Radiat Biol2022
35939275Benchmark dose modeling of transcriptional data: a systematic approach to identify best practices for study designs used in radiation research.Int J Radiat Biol2022
35939057Deploying elements of scoping review methods for adverse outcome pathway development: a space travel case example.Int J Radiat Biol2022
35902794Duplex sequencing identifies genomic features that determine susceptibility to benzo(a)pyrene-induced in vivo mutations.BMC Genomics2022
36271823Impact of sampling time on the detection of mutations in rapidly proliferating tissues using transgenic rodent gene mutation models: A review.Environ Mol Mutagen2022
36165699A Transformative Vision for an Omics-Based Regulatory Chemical Testing Paradigm.Toxicol Sci2022
35315142AOP report: Development of an adverse outcome pathway for oxidative DNA damage leading to mutations and chromosomal aberrations.Environ Mol Mutagen2022
  • 1 - 50 of 452

Recommended Authors

Ontario Institute for Cancer Research, University of Toronto
Career Start Year 2014
Number of shared co-authors 1
University of California los angeles
Career Start Year 2013
Number of shared co-authors 1
Boston Children's Hospital
Career Start Year 2012
Number of shared co-authors 1
University Health Network
Career Start Year 2011
Number of shared co-authors 1
Syngenta International Research Centre
Career Start Year 2006
Number of shared co-authors 1
Oregon State University
Career Start Year 2006
Number of shared co-authors 0
Career Start Year 2006
Number of shared co-authors 1
INSERM UMR-S1124, Universite Paris Cite
Career Start Year 2005
Number of shared co-authors 0
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 1
Bioinformatics Research Center, North Carolina State University
Career Start Year 2004
Number of shared co-authors 5
Oregon State University
Career Start Year 2003
Number of shared co-authors 0
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 1
National Institute of Environmental Health Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 1
National Center for Toxicological Research (NCTR)
Career Start Year 2000
Number of shared co-authors 5
SAS Institute Inc Cary
Career Start Year 2000
Number of shared co-authors 5
Pacific Northwest National Laboratory
Career Start Year 1994
Number of shared co-authors 2
Queen's University
Career Start Year 1994
Number of shared co-authors 3
Institute for Global Food Security, Queen's University Belfast
Career Start Year 1994
Number of shared co-authors 1
SAS Institute
Career Start Year 1994
Number of shared co-authors 4
North Carolina State University, USA Center for Human Health and the Environment
Career Start Year 1993
Number of shared co-authors 1
F. Hoffmann-La Roche Ltd
Career Start Year 1993
Number of shared co-authors 2
National Institute of Environmental Health Sciences
Career Start Year 1988
Number of shared co-authors 1
Novartis
Career Start Year 1988
Number of shared co-authors 0
Institute for Integrative Toxicological Sciences, Michigan State University
Career Start Year 1987
Number of shared co-authors 1
National Institute of Environmental Health Sciences
Career Start Year 1985
Number of shared co-authors 2
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Career Start Year 1984
Number of shared co-authors 2
Brown School of Public Health
Career Start Year 1984
Number of shared co-authors 0
Chulabhorn Research Institute
Career Start Year 1978
Number of shared co-authors 0
University of California los angeles
Career Start Year 1970
Number of shared co-authors 5
Institute of Experimental Medicine of the Czech Academy of Sciences
Career Start Year 1966
Number of shared co-authors 2

Collaborators

Carleton University
Co-authored papers 44
Harvard Medical School, Beth Israel Hospital
Co-authored papers 33
Co-authored papers 12
University of Toronto
Co-authored papers 10
Co-authored papers 9
National Institute of Environmental Health Sciences
Co-authored papers 8
Washington University School of Medicine
Co-authored papers 6
University of Regina
Co-authored papers 5
National Center for Toxicological Research
Co-authored papers 4
Center for Environmental Measurement and Modeling
Co-authored papers 4
National Institute of Environmental Health Sciences/National Institutes of Health
Co-authored papers 4
Co-authored papers 4
University of Leicester
Co-authored papers 3
McGill University
Co-authored papers 3
National Institute of Environmental Health Sciences
Co-authored papers 3
McGill University
Co-authored papers 3
Wellcome Sanger Institute
Co-authored papers 2
National Center for Environmental Assessment
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
University of Michigan ann arbor
Co-authored papers 2
New York University School of Medicine
Co-authored papers 2
Center for Devices and Radiological Health
Co-authored papers 2
Co-authored papers 2
National Institute of Environmental Health Sciences
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of Copenhagen
Co-authored papers 2
University of California Los Angeles
Co-authored papers 1
University of Oklahoma
Co-authored papers 1